Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT06135870
- Status
- Recruiting
Conditions
- Fibroid
- Leiomyoma
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Study Details
The investigators are evaluating the role of senescent cells in uterine fibroids.
Key Dates
- Start date
- Nov 1, 2023
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Women with fibroids undergoing elective hysterectomy or myomectomyWomen between the age of 18-55 with fibroids undergoing elective hysterectomy or myomectomy
Primary Outcome Measure
Develop an atlas to comprehensively quantify the rate of senescent cell (SnC) types in fibroid and myometrium tissue samples [ Time Frame: 5 years ]
Central Contacts
- James Segars, MD410-614-2000
- Bhuchitra Singh, MD, MPH, MBA410-614-2000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | Rachel Mitchel |
Find similar trials in Baltimore, MD
By research site
Related Studies
- Effects of Simvastatin on Uterine Leiomyoma SizePHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- Prescription of Letrozole for Uterine MyomaPHASE4 · Recruiting · University of California, San Francisco · Los Angeles, California
- An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related SymptomsRecruiting · Zenchi, Inc. · Las Vegas, Nevada